Gencurix Inc. (KOSDAQ:229000)
 1,488.00
 -7.00 (-0.47%)
  Oct 31, 2025, 3:30 PM KST
Gencurix Market Cap
Gencurix has a market cap or net worth of 23.98 billion as of October 31, 2025. Its market cap has decreased by -41.51% in one year.
Market Cap 
 23.98B
Enterprise Value 
 26.59B
Revenue 
 3.39B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
1,488.00
Market Cap Chart
Since April 5, 2017, Gencurix's market cap has decreased from 73.36B to 23.98B, a decrease of -67.31%. That is a compound annual growth rate of -12.22%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 24.10B | -19.76% | 
| Dec 30, 2024 | 30.03B | -64.40% | 
| Dec 28, 2023 | 84.35B | 82.80% | 
| Dec 29, 2022 | 46.15B | -60.69% | 
| Dec 30, 2021 | 117.40B | 11.19% | 
| Dec 30, 2020 | 105.58B | 18.66% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 39.50T | 
| ALTEOGEN | 25.46T | 
| SK Biopharmaceuticals | 8.97T | 
| Yuhan | 8.77T | 
| HLB Co., Ltd. | 6.25T | 
| Peptron | 6.18T | 
| PharmaResearch | 5.57T |